| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/20/1991 | CN1011660B Drug composition containing trinitrobenzene and river snail |
| 02/19/1991 | US4994556 Antitumor agents |
| 02/19/1991 | US4994271 BMY-40800 antitumor antibiotics |
| 02/19/1991 | CA1280379C Peptides and compositions |
| 02/18/1991 | WO1991002525A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
| 02/18/1991 | CA2062745A1 Composition based on hydrated lipidic lamellar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical composition, particularly dermatological composition containing it |
| 02/13/1991 | EP0412466A2 Preparation of a stable factor VIII |
| 02/13/1991 | CN1049103A Method of freezing red blood cells |
| 02/13/1991 | CN1049098A Comprehensive myopia-treating candle instrument |
| 02/12/1991 | WO1991001739A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | US4992363 Storage solution of sodium citrate, sodium, calcium, and(or) potassium chloride and(or) sodium phosphate |
| 02/12/1991 | US4992274 Tissue plasminogen activator A-chain/urokinase B-chain hybrid protein |
| 02/12/1991 | CA2064787A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/10/1991 | CA2021059A1 Process for encapsulation of biologicals |
| 02/07/1991 | WO1990014068A3 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof |
| 02/06/1991 | EP0411678A1 Method for the production of erythropoietin |
| 02/05/1991 | US4990333 Treating with isolated omental lipid containing gangliosides |
| 02/05/1991 | US4990132 Carrying out |
| 02/05/1991 | CA1279823C Pharmaceutical and dietary composition for pre-menstrual syndrome |
| 01/30/1991 | EP0409957A1 Biological fluids purification systems |
| 01/29/1991 | WO1991001751A1 Biological preparation and its use |
| 01/29/1991 | WO1991001738A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | WO1991001731A1 Riboflavin composition and method for production |
| 01/29/1991 | US4988676 Suppression of antigens, mitogens or alloantigens in blood as antitumor agents |
| 01/29/1991 | US4988515 Antiischemic agents |
| 01/29/1991 | CA2064036A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | CA2063789A1 Riboflavin composition and method for production |
| 01/29/1991 | CA1279591C High level production of bovine growth hormone |
| 01/24/1991 | DE3923848A1 De-masking of autologous immunocyte(s) - used in immuno-therapy of tumours |
| 01/23/1991 | EP0409655A2 Method for stimulating proliferation of peripheral blood lymphocytes |
| 01/23/1991 | EP0409473A2 A process for obtaining the gangliosides from nervous tissue of mammalians and for the treatment of psychoorganic diseases with said material compositons |
| 01/23/1991 | EP0408770A1 New sulfated polysaccharide, pharmaceutically acceptable salts thereof, preparation thereof, and drug containing the same as active ingredient |
| 01/22/1991 | WO1991002050A1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
| 01/22/1991 | WO1991001370A1 Protection of nk cell cytolytic activity in pbmc |
| 01/22/1991 | WO1991001369A1 Preparation of human adherent lymphokine-activated killer (a-lak) cells |
| 01/22/1991 | US4987237 Immunostimulant suitable for coupling to other materials |
| 01/22/1991 | CA2064072A1 Preparation of human adherent lymphokine-activated killer (a-lak) cells |
| 01/22/1991 | CA2063813A1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
| 01/22/1991 | CA2063788A1 Protection of nk cell cytolytic activity in pbmc |
| 01/16/1991 | EP0408444A2 Galactan extracted Klebsiella, process for its preparation and its use as a medicament |
| 01/16/1991 | EP0408029A1 Method of fractionating plasma protein |
| 01/16/1991 | EP0407939A1 Antiviral antibiotic BU-3889V |
| 01/16/1991 | CN1011197B Preparing method of liquid gelatin from donkey-hide gelatin or other animal gelatin |
| 01/15/1991 | US4985466 Antitumor agents |
| 01/15/1991 | US4985406 Central nervous system disorders, dopaminergic pathways |
| 01/15/1991 | US4985255 External preparations of melanogenesis-inhibitory agent |
| 01/15/1991 | US4985254 Extract from Infected Tissues Inoculated with a Poxvirus |
| 01/15/1991 | US4985246 Composition of feedstuff |
| 01/14/1991 | WO1991000734A1 Solid and aqueous treated products of lamprey |
| 01/14/1991 | CA2037054A1 Processed solid material and processed aqueous material of lamprey |
| 01/12/1991 | CA2020794A1 Galactanne extracted from klebsiella, process for its obtention and use as medicament |
| 01/12/1991 | CA2019893A1 Method of fractionating plasma protein |
| 01/11/1991 | CA2020800A1 Antiviral antibiotic bu-3889v |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1991000098A1 Anti-inflammatory preparation and method of obtaining it |
| 01/10/1991 | WO1990014427A3 Multivalent repressor of gene function |
| 01/09/1991 | EP0406745A1 Antibiotic GE 2270 factors A1, A2, A3 and H |
| 01/09/1991 | EP0406732A2 Highly concentrated and low-viscosity surfactant suspension |
| 01/09/1991 | EP0406557A2 Multivalent repressor of gene function |
| 01/09/1991 | EP0406369A1 Virus inactivated blood product and method |
| 01/09/1991 | EP0406347A1 Anti-inflammatory and analgesic compounds, related compositions and methods for preparation and use thereof |
| 01/09/1991 | EP0406317A1 Method and means for immuno-stimulating blood treatment with mitogen |
| 01/09/1991 | CN1048324A Preparation of stone-dissolving medicine "rongshibao" |
| 01/08/1991 | US4983779 Coupling carbonyl compound with ester in organic solvent in presence of metallic reducing agent, titanium salt, amine base |
| 01/08/1991 | US4983163 Lactobacillus bacteria culture |
| 01/02/1991 | EP0406087A2 Antihypertensives and food and drinks containing such antihypertensives |
| 01/02/1991 | EP0405972A1 Device and process for cell capture and recovery |
| 01/02/1991 | CA1278514C Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process |
| 01/01/1991 | US4981792 Immunosuppressant compound |
| 12/31/1990 | WO1991000099A1 A bacterial preparation for use in poultry |
| 12/31/1990 | CA2058990A1 Bacterial preparation for use in poultry |
| 12/30/1990 | WO1991000293A1 Vasodilatory and immune suppressant peptides |
| 12/30/1990 | CA2063260A1 Vasodilatory and immune suppressant peptides |
| 12/27/1990 | WO1990015863A1 Isolation growth and differentiation of human muscle cells |
| 12/27/1990 | WO1990015620A1 Platelet aggregation inhibitors |
| 12/27/1990 | WO1990015612A1 Glucose free primary anticoagulant for blood |
| 12/27/1990 | EP0404661A2 Use of lipopolysaccharide extracts of gram (-) bacteria for the preparation of a medicament to facilitate the cicatrisation of the skin |
| 12/27/1990 | EP0404660A2 Use of glycoprotein complex extracts of gram (-) bacteria for the preparation of a medicament to facilitate the cicatrisation of the skin and a method for its preparation |
| 12/27/1990 | EP0404370A2 Resolution of emulsions formed in the production of pharmaceuticals |
| 12/27/1990 | EP0404300A2 Process for production of eicosapentaenoic acid-containing phospholipids |
| 12/27/1990 | EP0404055A1 Ghilanten: antimetastatic principle from the south american leech, haementeria ghilianii |
| 12/27/1990 | CA2388770A1 Platelet aggregation inhibitors |
| 12/27/1990 | CA2058955A1 Isolation growth and differentiation of human muscle cells |
| 12/26/1990 | CN1047971A Itch allaying and skin protection liniment and its mfg. method |
| 12/25/1990 | US4980277 Cryoprotectant solution and method |
| 12/25/1990 | US4980174 Implanting monoamine-producing living cells in central nervous system |
| 12/25/1990 | US4980149 Reduction of the toxic effects caused by anthraquinone drugs |
| 12/22/1990 | CA2013614A1 Process for production of eicosapentaenoic acid-containing phospholipid and use of said lipid |
| 12/19/1990 | EP0403292A2 Ruminant feedstuff additives |
| 12/19/1990 | EP0403031A2 Fractionation system and method for cellular suspensions |
| 12/19/1990 | CN1010828B Process for preparing drugs of treating traumatic wound |
| 12/18/1990 | US4978540 Production of frozen foods and other products |
| 12/16/1990 | WO1990015613A1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 12/13/1990 | WO1990015601A1 Reducing the spread of infection by blood handling equipment |
| 12/13/1990 | WO1990014843A1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy |
| 12/13/1990 | WO1990014765A1 Introduction of bacteria in ovo |
| 12/13/1990 | DE3922089A1 Neue proteine und ihre herstellung New proteins and their production |
| 12/13/1990 | CA2032484A1 Reducing the spread of infection by blood handling equipment |
| 12/12/1990 | EP0402208A1 Mixture of Vitamin A in physiological dosis and different active ingredients having therapeutic effect |
| 12/12/1990 | EP0401997A1 Process to prepare metastasis-inhibitory factor |